S100A1 gene therapy in small and large animals

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Gene Therapy

Background:

• Myocardial in vivo gene delivery is crucial for studying protein function in cardiac health and disease.
• Rodent models aid in screening and mechanistic studies, while large animal models are vital for translational research.
• Viral vectors are employed to deliver genes to the myocardium for protein expression.

Purpose of the Study:

• To investigate the effects of S100A1 protein on cardiac function, hypertrophy, and energy metabolism.
• To utilize myocardial gene therapy in small and large animal models of post-ischemic heart failure.
• To demonstrate the therapeutic potential of S100A1 in cardiovascular disease models.

Main Methods:

• Cloning a gene of interest into a viral vector with a specific promoter.
• Administering the viral vector via targeted routes to the heart in animal models.
• Assessing cardiac contractile function, hypertrophy, and energy state post-gene delivery.

Main Results:

• Successful myocardial gene delivery of S100A1 was achieved in both small and large animal models.
• S100A1 demonstrated positive inotropic effects, enhancing cardiac contractility.
• S100A1 exhibited antihypertrophic and pro-energetic actions, mitigating adverse cardiac remodeling and improving energy metabolism.

Conclusions:

• Myocardial gene therapy is a robust approach for evaluating protein function in cardiovascular research.
• The small calcium sensor protein S100A1 possesses significant therapeutic potential for post-ischemic heart failure.
• S100A1’s beneficial effects on contractility, hypertrophy, and energy metabolism highlight its role in cardiac protection and function.